Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies' Adoption of New Sales Models and Technologies - GBI Research Reports

Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies' Adoption of New Sales Models and Technologies

Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies' Adoption of New Sales Models and Technologies - GBI Research Reports
Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies' Adoption of New Sales Models and Technologies
Published Oct 01, 2010
120 pages — Published Oct 01, 2010
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GBI Research's report, 'Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increases Pharmaceutical Companies' Adoption of New Sales Models and Technologies', provides in-depth analysis of trends, issues and challenges in this industry. The report analyzes the sales force effectiveness strategies that shape the industry dynamics for the key geographies: the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Further, the report provides competitive benchmarking for the leading companies and analyzes the licensing agreements that shape the global markets.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

The scope of this report includes:
- Annualized market data from 2009, forecast forward to 2016.
- Analysis of the leading technology in this space
- Analysis of the R&D models
- Market characterization
- Key drivers and barriers that have a significant impact on the market.
- Competitive benchmarking of leading companies.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
- Develop key strategies to reduce expenditure on sales force and by increasing efficiency
- Develop and understanding of how companies use tools and models in order to improve the sales force productivity
- Make informed decisions with respect to sales force effectiveness
- Identify the leading technology providers for collaborations along with their key capabilities
- Make more informed business decisions from the insightful and in-depth analysis of the sales force effectiveness and the factors shaping it.

  
Source:
Document ID
GBIHC038MR
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
1 Table of Contents35
1.1 List of Tables51
1.2 List of Figures62
2 Sales Force Effectiveness in the Pharmaceutical Industry Introduction82
2.1 GBI Research Report Guidance91
3 The Need for Sales Force Effectiveness107
3.1 Introduction101
3.1.1 Shift in product portfolio101
3.1.2 Regulatory Tightening 111
3.1.3 Specialty care focus121
3.1.4 Shift of power 121
3.1.5 Industry consolidation 121
3.1.6 Non-personal promotion121
3.1.7 R&D Costs Increase against Revenue Growth for the Top 10 Pharmaceutical Companies132
3.1.8 Layoff in the Pharmaceutical Companies 151
3.1.9 Shrinking Field Force Model161
4 Sales Force Sizing 175
4.1 Introduction171
4.2 Affordability 171
4.3 Workload build-up171
4.3.1 Case 1181
4.3.2 Case 2191
4.4 Competitive Benchmarking 191
4.5 Promotion Response Modeling202
5 Sales Force Recruitment 228
5.1 Introduction221
5.2 Sales Force Recruitment Strategy221
5.2.1 Recruiting Strategy 231
5.2.2 Business Objectives 231
5.2.3 Identify the specific metrics that will define success231
5.2.4 Define Job Requirements 241
5.2.4.1 Define work requirements 241
5.2.4.2 Define Key worker Competencies241
5.2.5 Establishing Assessment Validity 241
5.2.6 Implementation 241
5.3 Recruitment/Employment Process Outsourcing 251
5.3.1 Case Studies251
5.3.1.1 An International Pharmaceutical Company and its RPO251
5.3.1.2 AstraZeneca &RPO262
5.4 The Diversity and Inclusion Imperative from Novartis281
5.4.1 Improving Representation291
5.4.2 Building Capability291
5.4.3 Driving Ownership and Accountability291
5.4.4 Ensuring Sustainability291
6 Sales Force Training &Compensation3010
6.1 Introduction301
6.2 Models301
6.2.1 Survey on Sales Force Training 301
6.3 Specialty Care Training 311
6.3.1 Sanofi Aventis and their Specialty Care Training 311
6.3.1.1 Selling approach and it Adoption 311
6.3.1.2 Effectiveness in the Hospital Market311
6.3.1.3 Accountability Culture 311
6.3.1.4 Skill Development for Hospital Market321
6.3.1.5 Skills and Fine-Tuning321
6.3.1.6 Understanding the Value321
6.3.2 Continuous Assessments 331
6.4 Leaders Take the Initiative 331
6.4.1 Five Step Model341
6.4.1.1 Pinpoint341
6.4.1.3 Feedback341
6.4.1.4 Reinforce341
6.4.1.5 Evaluate341
6.4.2 Impact of Behavioral Coaching 343
6.5 Tailored Incentive Management 371
6.5.1 Plan authoring and simulation381
6.5.2 Schema Calculation 381
6.5.3 Credit Allocation and Payment 381
6.5.4 Reporting &Analysis 382
7 Sales Models 4037
Introduction401
7.2 Key account Management 411
7.2.1 Introduction411
7.2.2 Key Account Management Process411
7.2.2.1 Key Account Identification and Prioritization 423
7.2.2.2 Understanding needs and developing customer insights 451
7.2.2.3 Forming the virtual account team 451
7.2.2.4 Developing the strategic plan 461
7.2.2.5 Communicating and implementing the plan461
7.2.2.6 Reviewing the results471
7.2.3 Types of Key Account Management 471
7.2.3.1 Target Account Selling 471
7.2.3.2 Orchestrated Account Selling 471
7.2.3.3 Co-development Partnerships471
7.2.4 Case Studies 481
7.2.4.1 Lundbeck in UK and its Success481
7.2.4.2 Abbott Laboratories Sales Force Optimization496
7.3 Contract Sales Outsourcing 551
7.3.1 Contract Sales Representatives561
7.3.2 Sales Team Recruitment and Training561
7.3.3 Sales Data Analytics and Management571
7.3.4 Shared Sales Teams and Telesales571
7.3.5 Medical Science Liaisons571
7.3.6 The Evolving Model 581
7.3.7 Case Study 591
7.3.7.1 Quintiles the UK based Biotechnology Company591
7.4 Closed Loop Marketing 601
7.4.1 Benefits for Sales &Physicians 611
7.4.2 Benefits for Analytics 611
7.4.3 Benefits for Legal &Regulatory Departments 611
7.4.4 Benefits for Marketing 611
7.4.5 Case Studies 611
7.4.5.1 Wyeth and Closed Loop Marketing 614
7.5 Examining Strategies 651
7.5.1 Promotional Response Model 661
7.6 Survey on Sales and Marketing Strategies674
7.7 Sales Force Effectiveness Dashboards 711
7.8 Investment Priorities721
7.9 New Sales Strategies Implemented731
7.10 The Future Strategies to be Implemented743
8 Sales Force Effectiveness Efficiency Analysis 7740
8.1 Eli Lilly and Company811
8.1.1 Overview811
8.1.2 SG&A and R&D Spending 821
8.1.3 SG&A Analysis 831
8.2 Johnson &Johnson841
8.2.1 Overview841
8.2.2 SG&A and R&D Spending 851
8.2.3 SG&A Analysis 861
8.3 Pfizer, Inc.871
8.3.1 Overview871
8.3.2 SG&A and R&D Spending 881
8.3.3 SG&A Analysis 891
8.4 Merck &Co Inc901
8.4.1 Overview901
8.4.2 SGA and R&D Spending 911
8.4.3 SG&A Analysis 921
8.5 Sanofi-Aventis931
8.5.1 Overview931
8.5.2 SGA and R&D Spending 941
8.5.3 SG&A Analysis 951
8.6 Bristol-Myers Squibb961
8.6.1 Overview961
8.6.2 SGA and R&D Spending 971
8.6.3 SG&A Analysis 981
8.7 GlaxoSmithKline991
8.7.1 Overview991
8.7.2 SGA and R&D Spending 1001
8.7.3 SG&A Analysis 1011
8.8 Novo Nordisk1021
8.8.1 Overview1021
8.8.2 SGA vs. R&D Spending 1031
8.8.3 SG&A Analysis 1041
8.9 Allergan Inc.1051
8.9.1 Overview1051
8.9.2 SGA and R&D Spending 1051
8.9.3 SG&A Analysis 1061
8.10 Abbott Laboratories 1071
8.10.1 Overview1071
8.10.2 SGA and R&D Spending 1081
8.10.3 SG&A Analysis 1091
8.11 Genzyme Corporation1101
8.11.1 Company Overview1101
8.11.2 Business Description1101
8.11.3 SGA and R&D Spending 1111
8.11.4 SG&A Analysis 1121
8.12 Teva Pharmaceuticals1131
8.12.1 Overview1131
8.12.2 SGA and R&D Spending 1131
8.12.3 SG&A Analysis 1141
8.13 Astrazeneca 1151
8.13.1 Overview1151
8.13.2 SGA and R&D Spending 1151
8.13.3 SG&A Analysis 1161
9 Sales Force Effectiveness in the Pharmaceutical Industry Appendix1174
9.1 Market Definitions1171
9.2 Abbreviations1171
9.3 Research Methodology1182
9.3.1 Coverage1181
9.3.2 Secondary Research1191
9.3.3 Primary Research1191
9.3.4 Expert Panel Validation1191
9.4 Contact Us1201
9.5 Disclaimer1201
9.6 Sources 1201

Table Of Contents

GBI Research Reports—GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.

About the Author


Cite this Report

  
MLA:
GBI Research Reports. "Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies' Adoption of New Sales Models and Technologies" Oct 01, 2010. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Sales-Force-Effectiveness-in-Pharmaceuticals-Cost-Pressures-Increase-Pharmaceutical-Companies-Adoption-of-New-Sales-Models-and-Technologies-2115-93>
  
APA:
GBI Research Reports. (2010). Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies' Adoption of New Sales Models and Technologies Oct 01, 2010. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GBI-Research-Reports/Sales-Force-Effectiveness-in-Pharmaceuticals-Cost-Pressures-Increase-Pharmaceutical-Companies-Adoption-of-New-Sales-Models-and-Technologies-2115-93>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.